BioCalth Receives Patent
September 13, 2004
1 Min Read
BioCalth Receives Patent
LA VERNE, Calif.BioCalthInternational Corp. (www.biocalth.com) was awarded U.S. PatentNo. 6,713,513 B2, covering a method for treating cartilage-related diseases. Thepatent relates to administering an effective amount of calcium L-threonate tosubjects suffering from cartilage-related diseases such as osteoarthritis orarticular cartilage damage.
BioCalth (www.biocalth.com) is the exclusive manufacturer anddistributor of the product, which is available as BioCalth.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like